Patents Assigned to SEROXO LIMITED
  • Monitoring cancer recurrence and progression
    Patent number: 11435341
    Abstract: The present invention provides rapid and simple methods of testing on whole blood samples for alerting cancer recurrence and assessing cancer progression relying on determination of the functionality of leucocytes (predominately neutrophils) to exhibit challenge-induced superoxide anion production with quantification by chemiluminescent measurement.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: September 6, 2022
    Assignee: SEROXO LIMITED
    Inventors: David Sarphie, Rubina Mian